As of 2025-07-16, the Fair Value of Botanix Pharmaceuticals Ltd (BOT.AX) is -0.05 AUD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.15 AUD, the upside of Botanix Pharmaceuticals Ltd is -134.54%.
With the market price of 0.15 AUD and our fair value calculation, Botanix Pharmaceuticals Ltd (BOT.AX) is not a good investment. Investing in BOT.AX stocks now will result in a potential loss of 134.54%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | -16.73 | -3.33 | -13.17 | -9.15 | -13.87 | -11.25 |
| YoY growth | 1.81% | 80.07% | -295.04% | 30.50% | -51.52% | -46.84% |
| Market Cap (mil) | 568.73 |
| P/E | |
| Forward P/E |
| EPS | -0.01 |
| Avg earnings growth rate | -46.84% |
| TTM earnings | -39.29 |